BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Y, Shen LY, Fu H, Dong B, Yang HL, Yan WP, Kang XZ, Dai L, Zhou HT, Yang YB, Liang Z, Chen KN. P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma. Dis Esophagus 2017;30:1-10. [PMID: 27868288 DOI: 10.1111/dote.12522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Schirripa A, Sexl V, Kollmann K. Cyclin-dependent kinase inhibitors in malignant hematopoiesis. Front Oncol 2022;12:916682. [DOI: 10.3389/fonc.2022.916682] [Reference Citation Analysis]
2 Yan C, Liu Q, Jia R. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes. Front Oncol 2022;12:829045. [DOI: 10.3389/fonc.2022.829045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang HL, Zhao XK, Zhou FY, Song X, Li LY, Huang GR, Bao QD, Lei LL, Yang HJ, Li L, Xu RH, Li AL, Wang XZ, Han WL, Ren JL, Wang LD. Characterization of E-cadherin expression in normal mucosa, dysplasia and adenocarcinoma of gastric cardia and its influence on prognosis. World J Gastrointest Oncol 2022; 14(1): 265-277 [DOI: 10.4251/wjgo.v14.i1.265] [Reference Citation Analysis]
4 Huang J, Wang X, Zhang X, Chen W, Luan L, Song Q, Wang H, Liu J, Xu L, Xu Y, Shen L, Tan L, Jiang D, Su J, Hou Y. CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome. Front Genet 2021;12:616110. [PMID: 33995474 DOI: 10.3389/fgene.2021.616110] [Reference Citation Analysis]
5 Wang L, Han H, Dong L, Wang Z, Qin Y. Function of p21 and its therapeutic effects in esophageal cancer. Oncol Lett 2021;21:136. [PMID: 33552255 DOI: 10.3892/ol.2020.12397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
6 Palumbo A Jr, Meireles Da Costa N, Pontes B, Leite de Oliveira F, Lohan Codeço M, Ribeiro Pinto LF, Nasciutti LE. Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix. Cells 2020;9:E455. [PMID: 32079295 DOI: 10.3390/cells9020455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
7 Ohashi R, Angori S, Batavia AA, Rupp NJ, Ajioka Y, Schraml P, Moch H. Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients. Cancers (Basel) 2020;12:E465. [PMID: 32079343 DOI: 10.3390/cancers12020465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wu J, Liu L, Wu F, Qiu L, Luo M, Ke Q, Deng X, Luo Z. Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis. Dis Markers 2020;2020:6520259. [PMID: 31998417 DOI: 10.1155/2020/6520259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li T, Xu L, Teng J, Ma Y, Liu W, Wang Y, Chi X, Shao S, Dong Y, Zhan Q, Liu X. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2020;65:1032-41. [PMID: 31562612 DOI: 10.1007/s10620-019-05836-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Tian Z, Li Z, Zhu Y, Meng L, Liu F, Sang M, Wang G. Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC. Clin Exp Metastasis 2019;36:381-91. [PMID: 31197517 DOI: 10.1007/s10585-019-09974-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Guo R, Ma Y, Zhao M, Zhang W, An G, Chen B, Song Y, Xu H, Li Y. Polymorphism rs2395655 affects LEDGF/p75 binding activity and p21WAF1/CIP1 gene expression in esophageal squamous cell carcinoma. Cancer Med 2019;8:2313-24. [PMID: 30854807 DOI: 10.1002/cam4.2067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]